Live

FierceBiotechGilead loosens ties to Arcus after TIGIT dream finally ends in phase 3 failure FierceBiotechWith $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines Lonza NewsFDA-backed drug project tests modeling to reduce some human studies - Stock Titan Thermo FisherSaladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays - Clinical Lab Products Thermo FisherTD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance Lonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract model resilient enough for new growth - AD HOC NEWS FierceBiotechReplimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection 10x Genomics Blog10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience IlluminaClinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com Thermo FisherAssessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st Curiosis Inc.Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView WatersWaters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill

Cell 25 nov. 2025

Charting the landscape of cytoskeletal diversity in microbial eukaryotes

Publication date: Available online 31 October 2025Source: CellAuthor(s): Felix Mikus, Armando Rubio Ramos, Hiral Shah, Jonas Hellgoth, Marine Olivetta, Susanne...

Publication date: Available online 31 October 2025Source: CellAuthor(s): Felix Mikus, Armando Rubio Ramos, Hiral Shah, Jonas Hellgoth, Marine Olivetta, Susanne Borgers, Clémence Saint-Donat, Margarida Araújo, Chandni Bhickta, Paulina Cherek, Jone Bilbao, Estibalitz Txurruka, Yana Eglit, Nikolaus Leisch, Yannick Schwab, Filip Husnik, Sergio Seoane, Ian Probert, Paul Guichard, Virginie Hamel